(AVSU) American Century Trust - Overview
Etf: Equities, U.S. Companies, ESG Screened, All Cap
Dividends
| Dividend Yield | 1.12% |
| Yield on Cost 5y | 1.57% |
| Yield CAGR 5y | 20.08% |
| Payout Consistency | 98.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.0% |
| Relative Tail Risk | 1.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.78 |
| Alpha | 1.91 |
| Character TTM | |
|---|---|
| Beta | 0.976 |
| Beta Downside | 0.969 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.16% |
| CAGR/Max DD | 0.92 |
Description: AVSU American Century Trust December 29, 2025
The Avantis Responsible U.S. Equity ETF (AVSU) seeks to track a broad, diversified set of U.S. equities across all market-cap sizes while excluding companies that fail the sponsor’s ESG screens. The fund’s mandate is sector-agnostic, allowing exposure to the full spectrum of the U.S. market, but it systematically removes firms that score poorly on environmental, social, or governance criteria as judged by the portfolio management team.
Key quantitative points (as of the most recent quarterly filing, Q3 2024) include an expense ratio of 0.12 %, total assets of roughly $320 million, and an average turnover of 12 % per year. The top five holdings-Apple, Microsoft, Amazon, Alphabet, and Johnson & Johnson-collectively represent about 22 % of assets, reflecting a bias toward large-cap technology and health-care. Sector weights are roughly 45 % technology, 20 % health-care, and 15 % consumer discretionary, aligning with the broader U.S. equity market but with a modest tilt toward growth-oriented industries that have shown resilience in the current low-inflation environment. The ETF’s ESG filter has been validated by MSCI, which assigns it a “AAA” rating for ESG integration, suggesting a lower exposure to carbon-intensive or governance-riskier firms.
If you want a deeper, data-driven view of AVSU’s risk-adjusted performance and ESG impact metrics, a quick look at ValueRay’s analytical dashboard can help you spot any hidden drivers before you decide.
What is the price of AVSU shares?
Over the past week, the price has changed by +0.47%, over one month by +1.63%, over three months by +6.82% and over the past year by +18.35%.
Is AVSU a buy, sell or hold?
What are the forecasts/targets for the AVSU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 92.2 | 15.4% |
AVSU Fundamental Data Overview February 09, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 445.1m USD (445.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 445.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 445.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.51% (E(445.1m)/V(445.1m) * Re(9.51%) + (debt-free company))
Discount Rate = 9.51% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)